Jane Street’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History

Jane Street’s Portfolio UBIO Stock Details UBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-15,800	Closed	-$503K	–	5920
2018 Q1	$503K	Buy	15,800 +8,800	+126%	+$323K	﹤0.01%	3474
2017 Q4	$235K	Sell	7,000 -6,100	-47%	-$208K	﹤0.01%	4024
2017 Q3	$507K	Buy	+13,100	New	+$456K	﹤0.01%	3082
2016 Q4	–	Sell	-20,100	Closed	-$584K	–	4844
2016 Q3	$584K	Sell	20,100 -6,400	-24%	-$182K	﹤0.01%	2600
2016 Q2	$562K	Buy	+26,500	New	+$671K	﹤0.01%	2645

Other funds holding UBIO

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Jane Street's UBIO Position: Q1 2020 in Review

Jane Street sold out of Proshares UltraPro NASDAQ Biotechnology (UBIO) in Q1 2020, closing a stake of 56,492 shares — an estimated $1.85M sold.

Jane Street first reported a position in UBIO in Q4 2015 and held it in 12 quarters. The position peaked at $1.85M in Q4 2019. 1 fund tracked by Wall St. Rank holds UBIO as of Q1 2020.

Jane Street reported no remaining Proshares UltraPro NASDAQ Biotechnology position as of Q1 2020 after selling out during the quarter.
Jane Street sold 56,492 Proshares UltraPro NASDAQ Biotechnology shares in Q1 2020, an estimated $1.85M.
Jane Street first reported a position in Proshares UltraPro NASDAQ Biotechnology in Q4 2015 and held it in 12 quarters.
Jane Street's Proshares UltraPro NASDAQ Biotechnology position peaked at $1.85M in Q4 2019.
1 fund tracked by Wall St. Rank held Proshares UltraPro NASDAQ Biotechnology as of Q1 2020.

Based on Jane Street's 13F filing for Q1 2020, filed 15 May 2020.